Catalyst Wire Dossier Catalyst Wire Dossier

BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE

BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE · B. Braun Medical Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE, covering 2019-04-02 to 2024-10-25. Get the full timeline:

Most recent: FDA Approved: BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE — Supplemental Application (B. Braun Medical Inc.)

See pricing